This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Weinberg, O. K. Articles by Pietras, R. J. Search for Related Content PubMed PubMed Citation Articles by Weinberg, O. K. Articles by Pietras, R. J.

Aromatase Inhibitors in Human Lung Cancer Therapy

Departments of ¹ Medicine and ² Pathology and ³ Surgery, and ⁴ Jonsson Comprehensive Cancer Center, University of California at Los Angeles School of Medicine, Los Angeles, California

Requests for reprints: Richard J. Pietras, Department of Medicine-Hematology/Oncology, University of California at Los Angeles School of Medicine, 11-934 Factor Building, 10833 Le Conte Avenue, Los Angeles, CA 90095-1678. Phone: 310-825-9769; Fax: 310-825-6192; E-mail: rpietras{at}ucla.edu.

Lung cancer is the most common cancer in the world. It is a highly lethal disease in women and men, and new treatments are urgently needed. Previous studies implicated a role of estrogens and estrogen receptors in lung cancer progression, and this steroidal growth-stimulatory pathway may be promoted by tumor expression and activity of aromatase, an estrogen synthase. We found expression of aromatase transcripts and protein in human non–small cell lung cancer (NSCLC) cells using reverse transcription-PCR and Western immunoblots, respectively. Aromatase staining by immunohistochemistry was detected in 86% of archival NSCLC tumor specimens from the clinic. Further, biological activity of aromatase was determined in NSCLC tumors using radiolabeled substrate assays as well as measure of estradiol product using ELISA. Significant activity of aromatase occurred in human NSCLC tumors, with enhanced levels in tumor cells compared with that in nearby normal cells. Lung tumor aromatase activity was inhibited by anastrozole, an aromatase inhibitor, and treatment of tumor cells in vitro with anastrozole led to significant suppression of tumor cell growth. Similarly, among ovariectomized nude mice with A549 lung tumor xenografts, administration of anastrozole by p.o. gavage for 21 days elicited pronounced inhibition of tumor growth in vivo. These findings show that aromatase is present and biologically active in human NSCLCs and that tumor growth can be down-regulated by specific inhibition of aromatase. This work may lead to development of new treatment options for patients afflicted with NSCLC. (Cancer Res 2005; 65(24): 11287-91)

This article has been cited by other articles:

				Y. Chen, N. Guggisberg, M. Jorda, A. Gonzalez-Angulo, B. Hennessy, G. B. Mills, C.-K. Tan, and J. M. Slingerland Combined Src and Aromatase Inhibition Impairs Human Breast Cancer Growth In vivo and Bypass Pathways Are Activated in AZD0530-Resistant Tumors Clin. Cancer Res., May 15, 2009; 15(10): 3396 - 3405. [Abstract] [Full Text] [PDF]

				L. Diaz, I. Ceja-Ochoa, I. Restrepo-Angulo, F. Larrea, E. Avila-Chavez, R. Garcia-Becerra, E. Borja-Cacho, D. Barrera, E. Ahumada, P. Gariglio, et al. Estrogens and Human Papilloma Virus Oncogenes Regulate Human Ether-a-go-go-1 Potassium Channel Expression Cancer Res., April 15, 2009; 69(8): 3300 - 3307. [Abstract] [Full Text] [PDF]

				G. Zhang, X. Liu, A. M. Farkas, A. V. Parwani, K. L. Lathrop, D. Lenzner, S. R. Land, and H. Srinivas Estrogen Receptor {beta} Functions through Nongenomic Mechanisms in Lung Cancer Cells Mol. Endocrinol., February 1, 2009; 23(2): 146 - 156. [Abstract] [Full Text] [PDF]

				H. Niikawa, T. Suzuki, Y. Miki, S. Suzuki, S. Nagasaki, J. Akahira, S. Honma, D. B. Evans, S.-i. Hayashi, T. Kondo, et al. Intratumoral Estrogens and Estrogen Receptors in Human Non-Small Cell Lung Carcinoma Clin. Cancer Res., July 15, 2008; 14(14): 4417 - 4426. [Abstract] [Full Text] [PDF]

				V. Mah, D. B. Seligson, A. Li, D. C. Marquez, I. I. Wistuba, Y. Elshimali, M. C. Fishbein, D. Chia, R. J. Pietras, and L. Goodglick Aromatase Expression Predicts Survival in Women with Early-Stage Non Small Cell Lung Cancer Cancer Res., November 1, 2007; 67(21): 10484 - 10490. [Abstract] [Full Text] [PDF]

				J. Shen, J. Liu, Y. Xie, B. A. Diwan, and M. P. Waalkes Fetal Onset of Aberrant Gene Expression Relevant to Pulmonary Carcinogenesis in Lung Adenocarcinoma Development Induced by In Utero Arsenic Exposure Toxicol. Sci., February 1, 2007; 95(2): 313 - 320. [Abstract] [Full Text] [PDF]

				G. J. Kelloff, S. M. Lippman, A. J. Dannenberg, C. C. Sigman, H. L. Pearce, B. J. Reid, E. Szabo, V. C. Jordan, M. R. Spitz, G. B. Mills, et al. Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer--A Plan to Move Forward Clin. Cancer Res., June 15, 2006; 12(12): 3661 - 3697. [Abstract] [Full Text] [PDF]